Status:
COMPLETED
Post Market Surveillance for Infanrix™
Lead Sponsor:
GlaxoSmithKline
Conditions:
Diphtheria
Acellular Pertussis
Eligibility:
All Genders
Brief Summary
The purpose of this study was to investigate the following questions through post-marketing surveillance: * Unknown/Unexpected adverse events and the serious adverse events. * The circumstances in wh...
Eligibility Criteria
Inclusion
- All children receiving Infanrix™ were eligible for this survey.
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2008
Estimated Enrollment :
1258 Patients enrolled
Trial Details
Trial ID
NCT00908115
Start Date
August 1 2003
End Date
June 23 2008
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Daegu, South Korea, 700-712